AbstractAmyloid fibers in human semen known as SEVI (semen-derived enhancer of viral infection) dramatically increase the infectivity of HIV and other enveloped viruses, which appears to be linked to the promotion of bridging interactions and the neutralization of electrostatic repulsion between the host and the viral cell membranes. The SEVI precursor PAP248–286 is mostly disordered when bound to detergent micelles, in contrast to the highly α-helical structures found for most amyloid proteins. To determine the origin of this difference, the structures of PAP248–286 were solved in aqueous solution and with 30% and 50% trifluoroethanol. In solution, pulsed field gradient (PFG)-NMR and 1H-1H NOESY experiments indicate that PAP248–286 is unfo...
PAP248-286 is a 39-residue fragment (residues 248 to 286) derived from protease cleavage of prostati...
PAP248-286 is a 39-residue fragment (residues 248 to 286) derived from protease cleavage of prostati...
Thesis (Ph.D.)--University of Rochester. School of Medicine & Dentistry. Dept. of Microbiology and I...
AbstractAmyloid fibers in human semen known as SEVI (semen-derived enhancer of viral infection) dram...
Semen-derived enhancer of viral infection (SEVI) is the term given to the amyloid fibrils formed by ...
AbstractIn previous in vivo studies, amyloid fibers formed from a peptide ubiquitous in human semina...
International audienceHuman semen contains peptides capable of forming amyloid fibrils termed semen-...
Amyloidogenic peptides present in human semen self-assemble into positively charged fibrils that mar...
Misfolding and amyloid aggregation of intrinsically disordered proteins (IDPs) are implicated in a v...
Despite its discovery over 30 years ago, human immunodeficiency virus (HIV) continues to threaten pu...
The semen-derived enhancer of viral infection (SEVI) is a positively charged amyloid fibril that is ...
Inhibiting the aggregation of amyloid peptides with endogenous peptides has broad interest due to th...
Semen-derived enhancer of virus infection (SEVI) fibrils are naturally abundant amyloid aggregates f...
AbstractPAP248–286 is a 39-residue fragment (residues 248 to 286) derived from protease cleavage of ...
Human Immunodeficiency Virus (HIV) affects millions of individuals worldwide. The primary mode of tr...
PAP248-286 is a 39-residue fragment (residues 248 to 286) derived from protease cleavage of prostati...
PAP248-286 is a 39-residue fragment (residues 248 to 286) derived from protease cleavage of prostati...
Thesis (Ph.D.)--University of Rochester. School of Medicine & Dentistry. Dept. of Microbiology and I...
AbstractAmyloid fibers in human semen known as SEVI (semen-derived enhancer of viral infection) dram...
Semen-derived enhancer of viral infection (SEVI) is the term given to the amyloid fibrils formed by ...
AbstractIn previous in vivo studies, amyloid fibers formed from a peptide ubiquitous in human semina...
International audienceHuman semen contains peptides capable of forming amyloid fibrils termed semen-...
Amyloidogenic peptides present in human semen self-assemble into positively charged fibrils that mar...
Misfolding and amyloid aggregation of intrinsically disordered proteins (IDPs) are implicated in a v...
Despite its discovery over 30 years ago, human immunodeficiency virus (HIV) continues to threaten pu...
The semen-derived enhancer of viral infection (SEVI) is a positively charged amyloid fibril that is ...
Inhibiting the aggregation of amyloid peptides with endogenous peptides has broad interest due to th...
Semen-derived enhancer of virus infection (SEVI) fibrils are naturally abundant amyloid aggregates f...
AbstractPAP248–286 is a 39-residue fragment (residues 248 to 286) derived from protease cleavage of ...
Human Immunodeficiency Virus (HIV) affects millions of individuals worldwide. The primary mode of tr...
PAP248-286 is a 39-residue fragment (residues 248 to 286) derived from protease cleavage of prostati...
PAP248-286 is a 39-residue fragment (residues 248 to 286) derived from protease cleavage of prostati...
Thesis (Ph.D.)--University of Rochester. School of Medicine & Dentistry. Dept. of Microbiology and I...